ANGLE plc (AGL) - Cash Flow Conversion Efficiency
Based on the latest financial reports, ANGLE plc (AGL) has a cash flow conversion efficiency ratio of -0.385x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (GBX-4.50 Million ≈ $-547.76 USD) by net assets (GBX11.69 Million ≈ $1.42K USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See how leveraged is ANGLE plc's balance sheet to measure how much of total assets are equity-financed.
ANGLE plc - Cash Flow Conversion Efficiency Trend (2001–2024)
This chart illustrates how ANGLE plc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check AGL cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
ANGLE plc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of ANGLE plc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Dianomi PLC
LSE:DNM
|
-0.364x |
|
Altona Rare Earths PLC
LSE:REE
|
-0.494x |
|
Green Leaf Innovations Inc.
NASDAQ:GRLFD
|
N/A |
|
DOLPHIN DRILL. A.S. NK 10
F:L33
|
N/A |
|
Wishbone Gold Plc
LSE:WSBN
|
-0.187x |
|
Velocity Composites plc
LSE:VEL
|
0.042x |
|
Global Partner Acq Corp
NASDAQ:GPACU
|
0.297x |
|
Konan Technology Inc.
KQ:402030
|
N/A |
Annual Cash Flow Conversion Efficiency for ANGLE plc (2001–2024)
The table below shows the annual cash flow conversion efficiency of ANGLE plc from 2001 to 2024. For the full company profile with market capitalisation and key ratios, see ANGLE plc (AGL) market capitalisation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | GBX18.44 Million ≈ $2.24K |
GBX-13.45 Million ≈ $-1.64K |
-0.729x | -15.70% |
| 2023-12-31 | GBX22.94 Million ≈ $2.79K |
GBX-14.46 Million ≈ $-1.76K |
-0.630x | -57.33% |
| 2022-12-31 | GBX40.06 Million ≈ $4.87K |
GBX-16.05 Million ≈ $-1.95K |
-0.401x | -15.32% |
| 2021-12-31 | GBX40.33 Million ≈ $4.91K |
GBX-14.01 Million ≈ $-1.70K |
-0.347x | -52.02% |
| 2020-12-31 | GBX34.34 Million ≈ $4.18K |
GBX-7.85 Million ≈ $-954.87 |
-0.229x | +27.02% |
| 2019-12-31 | GBX26.60 Million ≈ $3.24K |
GBX-8.33 Million ≈ $-1.01K |
-0.313x | +17.22% |
| 2019-04-30 | GBX19.34 Million ≈ $2.35K |
GBX-7.31 Million ≈ $-889.90 |
-0.378x | +11.80% |
| 2018-04-30 | GBX15.88 Million ≈ $1.93K |
GBX-6.81 Million ≈ $-828.82 |
-0.429x | +48.85% |
| 2017-04-30 | GBX8.81 Million ≈ $1.07K |
GBX-7.38 Million ≈ $-898.30 |
-0.838x | +7.83% |
| 2016-04-30 | GBX5.24 Million ≈ $636.95 |
GBX-4.76 Million ≈ $-579.40 |
-0.910x | -168.19% |
| 2015-04-30 | GBX10.09 Million ≈ $1.23K |
GBX-3.42 Million ≈ $-416.36 |
-0.339x | +16.30% |
| 2014-04-30 | GBX5.51 Million ≈ $671.02 |
GBX-2.23 Million ≈ $-271.93 |
-0.405x | -97.56% |
| 2013-04-30 | GBX6.79 Million ≈ $825.71 |
GBX-1.39 Million ≈ $-169.38 |
-0.205x | +16.39% |
| 2012-04-30 | GBX4.41 Million ≈ $536.08 |
GBX-1.08 Million ≈ $-131.53 |
-0.245x | -37.30% |
| 2011-04-30 | GBX4.53 Million ≈ $551.54 |
GBX-810.00K ≈ $-98.55 |
-0.179x | -61.09% |
| 2010-04-30 | GBX4.16 Million ≈ $505.67 |
GBX-461.00K ≈ $-56.09 |
-0.111x | +46.35% |
| 2009-04-30 | GBX3.82 Million ≈ $464.91 |
GBX-790.00K ≈ $-96.12 |
-0.207x | +34.06% |
| 2008-04-30 | GBX7.22 Million ≈ $878.59 |
GBX-2.26 Million ≈ $-275.46 |
-0.314x | +71.32% |
| 2007-04-30 | GBX5.70 Million ≈ $693.16 |
GBX-6.23 Million ≈ $-757.65 |
-1.093x | -303.88% |
| 2006-04-30 | GBX14.48 Million ≈ $1.76K |
GBX-3.92 Million ≈ $-476.83 |
-0.271x | 0.00% |
| 2005-04-30 | GBX14.48 Million ≈ $1.76K |
GBX-3.92 Million ≈ $-476.83 |
-0.271x | -5819.15% |
| 2004-04-30 | GBX10.99 Million ≈ $1.34K |
GBX52.00K ≈ $6.33 |
0.005x | +100.44% |
| 2003-04-30 | GBX546.00K ≈ $66.43 |
GBX-592.00K ≈ $-72.03 |
-1.084x | +4.59% |
| 2002-04-30 | GBX909.00K ≈ $110.60 |
GBX-1.03 Million ≈ $-125.69 |
-1.136x | -23.10% |
| 2001-04-30 | GBX1.30 Million ≈ $158.29 |
GBX-1.20 Million ≈ $-146.13 |
-0.923x | -- |
About ANGLE plc
ANGLE plc, a medical diagnostic company, develops cancer diagnostics products in the United Kingdom, Europe, North America, and internationally. The company develops Parsortix PC1 systems, a medical device for the capture and harvest of intact circulating tumour cells (CTCs) from metastatic breast cancer patient blood for subsequent user-validated downstream analysis. It also provides Portrait+ C… Read more